© 2000 by Oxford University Press
Journal of the National Cancer Institute, Vol. 92, No. 13, 1054-1064,
July 5, 2000
© 2000 Oxford University Press
Managing Menopausal Symptoms in Breast Cancer Survivors: Results of a Randomized Controlled Trial
Affiliations of authors: P. A. Ganz, T. R. Belin (Schools of Medicine and Public Health and Division of Cancer Prevention and Control Research, Jonsson Comprehensive Cancer Center), G. A. Greendale (Division of Geriatrics, Department of Medicine), L. Petersen, L. Zibecchi, B. Kahn (Division of Cancer Prevention and Control Research, Jonsson Comprehensive Cancer Center), University of California at Los Angeles.
Correspondence to: Patricia A. Ganz, M.D., Division of Cancer Prevention and Control Research, Jonsson Comprehensive Cancer Center at UCLA, Box 956900, Rm. A2-125 CHS, Los Angeles, CA 90095-6900 (e-mail: pganz{at}ucla.edu).
Background: Menopausal symptoms (e.g., hot flashes, vaginal dryness, and stress urinary incontinence) are very common in breast cancer survivors and cannot be managed with standard estrogen replacement therapy (ERT) in these patients. The purpose of this study was to test the efficacy of a comprehensive menopausal assessment (CMA) intervention program in achieving relief of symptoms, the improvement in quality of life (QOL), and sexual functioning in breast cancer survivors. Methods: Using a two-group, randomized controlled design, we assigned 76 postmenopausal breast cancer survivors with at least one severe target symptom either to the intervention group or to a usual-care group. Seventy-two women were evaluable at the end of the study period. The CMA intervention, delivered by a nurse practitioner, focused on symptom assessment, education, counseling and, as appropriate, specific pharmacologic and behavioral interventions for each of the three target symptoms. Psychosocial symptoms were assessed with the use of a self-report screening instrument, and distressed women were referred for counseling if needed. The intervention took place over a 4-month period. Outcomes measured were scores on a composite menopausal symptom scale, the RAND Short Form Health Survey Vitality Scale, and the Cancer Rehabilitation Evaluation System (CARES) Sexual Functioning Scale at baseline and at 4-month follow-up. All statistical tests were two-sided and were performed at the alpha = .05 significance level. Results: Patients receiving the intervention demonstrated statistically significant improvement (P = .0004) in menopausal symptoms but no significant change in vitality (P = .77). Sexual functioning was statistically significantly improved (P = .04) in the treatment group compared with the usual-care group. Conclusions: A clinical assessment and intervention program for menopausal symptom management in breast cancer survivors is feasible and acceptable to patients, leading to reduction in symptoms and improvement in sexual functioning. Measurable improvement in a general QOL measure was not demonstrated.
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  N. E. Avis Breast Cancer Survivors and Hot Flashes: The Search for Nonhormonal Treatments J. Clin. Oncol., November 1, 2008; 26(31): 5008 - 5010. [Full Text] [PDF]
|
|
|
|
 |
|
 K. Absolom, C. Eiser, L. Turner, W. Ledger, R. Ross, H. Davies, R. Coleman, B. Hancock, J. Snowden, D. Greenfield, et al. Ovarian failure following cancer treatment: current management and quality of life Hum. Reprod., November 1, 2008; 23(11): 2506 - 2512. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Hickey, C. Saunders, A. Partridge, N. Santoro, H. Joffe, and V. Stearns Practical clinical guidelines for assessing and managing menopausal symptoms after breast cancer Ann. Onc., October 1, 2008; 19(10): 1669 - 1680. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. W. Goodwin, S. J. Green, C. M. Moinpour, J. D. Bearden III, J. K. Giguere, C. S. Jiang, S. M. Lippman, S. Martino, and K. S. Albain Phase III Randomized Placebo-Controlled Trial of Two Doses of Megestrol Acetate as Treatment for Menopausal Symptoms in Women With Breast Cancer: Southwest Oncology Group Study 9626 J. Clin. Oncol., April 1, 2008; 26(10): 1650 - 1656. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. R. Schover Premature Ovarian Failure and Its Consequences: Vasomotor Symptoms, Sexuality, and Fertility J. Clin. Oncol., February 10, 2008; 26(5): 753 - 758. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. A. Ganz and G. A. Greendale Female Sexual Desire--Beyond Testosterone J Natl Cancer Inst, May 2, 2007; 99(9): 659 - 661. [Full Text] [PDF]
|
|
|
|
|
|
L. R. Schover Is the Fault in Our Steroids or in Our Selves? J. Clin. Oncol., August 1, 2006; 24(22): 3519 - 3521. [Full Text] [PDF]
|
|
|
|
|
|
J. B. Madalinska, M. van Beurden, E. M.A. Bleiker, H. B. Valdimarsdottir, J. Hollenstein, L. F. Massuger, K. N. Gaarenstroom, M. J.E. Mourits, R. H.M. Verheijen, E. B.L. van Dorst, et al. The Impact of Hormone Replacement Therapy on Menopausal Symptoms in Younger High-Risk Women After Prophylactic Salpingo-Oophorectomy J. Clin. Oncol., August 1, 2006; 24(22): 3576 - 3582. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. Grunfeld, M. N. Levine, and J. A. Julian In Reply J. Clin. Oncol., August 1, 2006; 24(22): 3711 - 3712. [Full Text] [PDF]
|
|
|
|
 |
|
 A. Nedrow, J. Miller, M. Walker, P. Nygren, L. H. Huffman, and H. D. Nelson Complementary and alternative therapies for the management of menopause-related symptoms: a systematic evidence review. Arch Intern Med, July 24, 2006; 166(14): 1453 - 1465. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. R. Schover, R. Jenkins, D. Sui, J. H. Adams, M. S. Marion, and K. E. Jackson Randomized Trial of Peer Counseling on Reproductive Health in African American Breast Cancer Survivors J. Clin. Oncol., April 1, 2006; 24(10): 1620 - 1626. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Kendall, M. Dowsett, E. Folkerd, and I. Smith Caution: Vaginal estradiol appears to be contraindicated in postmenopausal women on adjuvant aromatase inhibitors Ann. Onc., April 1, 2006; 17(4): 584 - 587. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. Grunfeld, M. N. Levine, J. A. Julian, D. Coyle, B. Szechtman, D. Mirsky, S. Verma, S. Dent, C. Sawka, K. I. Pritchard, et al. Randomized Trial of Long-Term Follow-Up for Early-Stage Breast Cancer: A Comparison of Family Physician Versus Specialist Care J. Clin. Oncol., February 20, 2006; 24(6): 848 - 855. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. J. Whelan and K. I. Pritchard Managing Patients on Endocrine Therapy: Focus on Quality-of-Life Issues Clin. Cancer Res., February 1, 2006; 12(3): 1056s - 1060s. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. G. M. Fan, N. Houede-Tchen, Q.-L. Yi, I. Chemerynsky, F. P. Downie, K. Sabate, and I. F. Tannock Fatigue, Menopausal Symptoms, and Cognitive Function in Women After Adjuvant Chemotherapy for Breast Cancer: 1- and 2-Year Follow-Up of a Prospective Controlled Study J. Clin. Oncol., November 1, 2005; 23(31): 8025 - 8032. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Frumovitz, C. C. Sun, L. R. Schover, M. F. Munsell, A. Jhingran, J. T. Wharton, P. Eifel, T. B. Bevers, C. F. Levenback, D. M. Gershenson, et al. Quality of Life and Sexual Functioning in Cervical Cancer Survivors J. Clin. Oncol., October 20, 2005; 23(30): 7428 - 7436. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. L. Stanton, C. A. Bernaards, and P. A. Ganz The BCPT Symptom Scales: A Measure of Physical Symptoms for Women Diagnosed With or at Risk for Breast Cancer J Natl Cancer Inst, March 16, 2005; 97(6): 448 - 456. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. C. Gotay Assessing Cancer-Related Quality of Life Across a Spectrum of Applications J Natl Cancer Inst Monographs, October 1, 2004; 2004(33): 126 - 133. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. Tchen, H. G. Juffs, F. P. Downie, Q.-L. Yi, H. Hu, I. Chemerynsky, M. Clemons, M. Crump, P. E. Goss, D. Warr, et al. Cognitive Function, Fatigue, and Menopausal Symptoms in Women Receiving Adjuvant Chemotherapy for Breast Cancer J. Clin. Oncol., November 15, 2003; 21(22): 4175 - 4183. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. J. Goodwin, J. T. Black, L. J. Bordeleau, and P. A. Ganz Health-Related Quality-of-Life Measurement in Randomized Clinical Trials in Breast Cancer--Taking Stock J Natl Cancer Inst, February 19, 2003; 95(4): 263 - 281. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. L. Loprinzi, D. L. Barton, J. A. Sloan, K. M. Zahasky, D. A. R. Smith, S. Pruthi, P. J. Novotny, E. A. Perez, and B. J. Christensen Pilot Evaluation of Gabapentin for Treating Hot Flashes Mayo Clin. Proc., November 1, 2002; 77(11): 1159 - 1163. [Abstract] [PDF]
|
|
|
|
|
|
T. D. Shanafelt, D. L. Barton, A. A. Adjei, and C. L. Loprinzi Pathophysiology and Treatment of Hot Flashes Mayo Clin. Proc., November 1, 2002; 77(11): 1207 - 1218. [Abstract] [PDF]
|
|
|
|
|
|
C. L. Van Patten, I. A. Olivotto, G. K. Chambers, K. A. Gelmon, T. G. Hislop, E. Templeton, A. Wattie, and J. C. Prior Effect of Soy Phytoestrogens on Hot Flashes in Postmenopausal Women With Breast Cancer: A Randomized, Controlled Clinical Trial J. Clin. Oncol., March 15, 2002; 20(6): 1449 - 1455. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. I. Pritchard Hormone Replacement in Women with a History of Breast Cancer Oncologist, August 1, 2001; 6(4): 353 - 362. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. L. Loprinzi and D. Barton Estrogen Deficiency: In Search of Symptom Control and Sexuality J Natl Cancer Inst, July 5, 2000; 92(13): 1028 - 1029. [Full Text] [PDF]
|
|